ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids battling Leukemia's return
Disease control Recruiting nowThis study is testing a drug called tafasitamab in children and teenagers with a very high-risk form of B-cell leukemia that has come back or hasn't responded to standard treatments like stem cell transplants. The main goals are to find a safe dose and see if the drug can help pr…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New cell therapy trial offers hope for tough blood cancers
Disease control Recruiting nowThis study is testing an experimental cell therapy called CTD402 for people aged 12 and older whose T-cell leukemia or lymphoma has come back or hasn't responded to other treatments. Participants receive a single infusion of these specially modified immune cells and are then moni…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: BIOHENG THERAPEUTICS US LLC • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC